ABLE Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Buy
977
+140
+17% +$165K 0.18% 95
2026
Q2
$1M Hold
837
– – 0.17% 96
2026
Q1
$770K Sell
837
-15
-2% -$15.2K 0.15% 106
2025
Q4
$916K Buy
852
+6
+0.7% +$5.74K 0.19% 89
2025
Q3
$645K Sell
846
-119
-12% -$88.6K 0.14% 108
2025
Q2
$752K Sell
965
-32
-3% -$24.9K 0.18% 97
2025
Q1
$823K Sell
997
-13
-1% -$10.8K 0.23% 79
2024
Q4
$780K Sell
1,010
-29
-3% -$24K 0.23% 79
2024
Q3
$920K Buy
1,039
+81
+8% +$72.8K 0.28% 63
2024
Q2
$867K Buy
958
+55
+6% +$44K 0.31% 59
2024
Q1
$702K Buy
903
+83
+10% +$59.1K 0.28% 66
2023
Q4
$478K Buy
820
+123
+18% +$71.8K 0.21% 87
2023
Q3
$374K Sell
697
-65
-9% -$33.5K 0.19% 94
2023
Q2
$357K Buy
762
+91
+14% +$38.2K 0.18% 87
2023
Q1
$230K Buy
+671
New +$226K 0.15% 114

Other funds holding LLY

ABLE Financial Group's LLY Position: Q3 2026 in Review

ABLE Financial Group increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $165K and bringing the position to 977 shares worth $1.13M. The position accounts for 0.18% of the portfolio, ranked #95.

ABLE Financial Group first reported a position in LLY in Q1 2023 and has held it in 15 quarters since. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • ABLE Financial Group held 977 shares of Eli Lilly worth $1.13M as of Q3 2026.
  • ABLE Financial Group bought 140 Eli Lilly shares in Q3 2026, an estimated $165K.
  • Eli Lilly made up 0.18% of ABLE Financial Group's portfolio in Q3 2026, its #95 holding.
  • ABLE Financial Group first reported a position in Eli Lilly in Q1 2023 and has held it in 15 quarters since.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on ABLE Financial Group's 13F filing for Q3 2026, filed 14 Oct 2026.